Pathogen | Duration of pre-infectious period (days)a | Duration of infectious-ness (days)b | Number positive samples | Median age of infected subjects (years) | Percent of infected subjects 18 years or older | Estimated basic reproductive number (R0) | Estimated reduction in effective contact rate | Estimated proportion of infections averted |
---|---|---|---|---|---|---|---|---|
Influenza A/H1N1 | 2 | 5 | 1413 | 9.0 | 47% | 1.60 (1.56–64) | 27.3% (19.2–35.4%) | 7.6% (5.2–9.7%) |
Influenza A/H3N2 | 2 | 5 | 1704 | 9.0 | 31% | 2.18 (2.12–2.28) | 66.5% (62.2–74.5%) | 3.1% (2.5–3.2%) |
Influenza B | 2 | 6 | 82 | 7.0 | 28% | 1.78 (1.48–2.09) | 83.8% (39.4–100%) | 7.8% (5.5–8.1%) |
RSV A | 5 | 11 | 745 | 2.0 | 20% | 2.33 (2.33–2.47) | 94.6% (70.7–100%) | 8.8% (6.4–9.1%) |
RSV B | 5 | 11 | 542 | 2.0 | 38% | 2.03 (1.93–2.17) | 85.6% (54.5–100%) | 9.2% (6.2–10.3%) |
hCoV | 3 | 3.5 | 1258 | 6.0 | 46% | 1.38 (1.35–1.41) | 16.2% (7.1–24.2%) | 5.6% (4.1–6.9%) |
AdV | 6 | 5.5 | 770 | 3.0 | 18% | 1.72 (1.61–1.83) | 49.5% (30.3–65.7%) | 6.2% (4.6–7.4%) |
HRV | 2 | 11 | 1077 | 4.0 | 35% | 1.40 (1.33–1.46) | 49.5% (30.3–65.7%) | 6.8% (4.7–8.2%) |
hMPV | 4 | 10.5 | 599 | 4.0 | 43% | 1.99 (1.79–2.19) | 52.5% (18.2–79.8%) | 3.0% (2.0–3.7%) |